Since the 1970s, liver disease in the UK has increased by more than 400%, particularly in people under 65 – in marked contrast to all other major causes of death which have been decreasing in younger ...

Doctors are ordering too many liver-related blood tests at the same time, new research shows, which may lead to unneeded worry, biopsies and costs. Instead of 'overtesting', the researchers say, ...

Novel therapies based on a process known as RNA interference (RNAi) hold great promise for treating a variety of diseases by blocking specific genes in a patient’s cells. Many of the earliest RNAi ...

Until recently, standard 2D cell culture of cancer cell lines, such as the hepatoma-derived HepG2 cells, has served as an acceptable model for acute liver cellular toxicity testing. However, many ...

Data Bridge Market Research has published a detailed report on the Liver Panel Testing market. This market research report was prepared after analyzing the impact of COVID-19 and monitoring the market ...

Mitochondrial impairment is a major mechanism of action (MoA) causing drug-induced liver injury (DILI), as evidenced by drugs that have received black box warnings, 1 such as Amiodarone (used to treat ...

The European Medicines Agency's (EMA's) Pharmacovigilance Risk Assessment Committee (PRAC) recommended liver function testing at least monthly for women taking ulipristal acetate (Esmya, Gedeon ...